Front-line paclitaxel–vinorelbine versus paclitaxel–carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial-Reference-Cited by-同舟云学术

Front-line paclitaxel–vinorelbine versus paclitaxel–carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial

Published:2004-07 Issue:7 Volume:15 Page:1048-1055
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Stathopoulos G.P.,Veslemes M.,Georgatou N.,Antoniou D.,Giamboudakis P.,Katis K.,Tsavdaridis D.,Rigatos S.K.,Dimitroulis I.,Bastani S.,Loukides S.,Vergos K.,Marossis K.,Grigoratou T.,Kalatzi E.,Charalambatou M.,Paspalli A.,Michalopoulou P.,Stoka M.,Gerogianni A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/15/7/1048/676120/mdh260.pdf

Reference52 articles.

1. Non-small Cell Lung Cancer. Collaborative Groups. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials,1995

2. Mitanycil, ifosfamide and cisplatin in unresectable non-small cell lung cancer: Effects on survival and quality of life;Cullen,1999

3. Integration of New Agents into the Treatment of Advanced Non-Small Cell Lung Cancer;Johnson;Educational Book. Alexandria, VA: American Society of Clinical Oncology,2000

4. Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung, randomized trial investigation in two dosage schedule;Kelsen,1981

5. Chemotherapy for metastatic non-small cell bronchogenic carcinoma EST 2575, generation V—a randomized comparison of four cis-platin containing regimens;Ruckdeschel,1985

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Best first-line therapy for people with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status;Cochrane Database of Systematic Reviews;2023-07-07

2. Identification of cardiotoxicity related to non-small cell lung cancer (NSCLC) treatments: A systematic review;Frontiers in Pharmacology;2023-06-13

3. Three-week Cycles of Paclitaxel-Carboplatin Administered Concurrently with Radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer: 10-Year Single-Centre Experience;Hong Kong Journal of Radiology;2022-09-26

4. Efficacy and Safety of Lipegfilgrastim in Lung Cancer Patients Receiving Myelosuppressive Chemotherapy in a Real-World Setting: Results of an Analysis of Pooled Data from Two Non-Interventional European Studies;Oncology Research and Treatment;2021-01-21

5. Assessment of the External Validity of the National Comprehensive Cancer Network and European Society for Medical Oncology Guidelines for Non–Small-Cell Lung Cancer in a Population of Patients Aged 80 Years and Older;Clinical Lung Cancer;2017-09